menu toggle

The essential guide to drug commercialization

A handbook for selecting solutions and partners

Additional Insights

Communicating With Your Payers_467x250

Insight

Cencora PayerPulse: The unintended consequences of the Inflation Reduction Act (IRA)


AmerisourceBergen
September 2024

Video 2

Insight

Drug advertisement in Canada: What you need to know


AmerisourceBergen
September 2024

Doctor

Insight

Regulatory compliance: Navigating the Canadian landscape for specialty products


AmerisourceBergen
September 2024

us captitol

Stay informed about US Health Policy News

Health Policy Weekly

us captitol

Health Policy weekly recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry, particularly pharmaceutical, biotech, and device manufacturers, providers, and managed care.

Developed by a multi-disciplinary editorial board that includes health policy and reimbursement strategy experts, Health Policy Weekly delivers key insights to your inbox every week. 

us captitol
hta quarterly

Keep up on key global health technology assessment news

HTA Quarterly

hta quarterly

Each edition of HTA Quarterly provides insights and analysis from global experts with local market expertise on key priorities and perspectives affecting HTA.

From therapeutic area spotlights to geographic reviews to critical industry topics, keep current on HTA activity around the globe with HTA Quarterly.

hta quarterly
biopharma commercialization

Global Pharma Services

biopharma commercialization
Each investment we make is focused on connecting healthcare stakeholders to accelerate healthier futures. Our unrivaled expertise powers us in our vision to help you fully realize your product’s power—through the patients it reaches and the strategic outcomes it delivers. Learn more about our end to end suite of commercialization solutions for biopharma companies.
biopharma commercialization